Debut pop of 17% pares amid AI selloff; company closes with $1.8 trillion valuation
Indian government bonds saw slight gains, reflecting the upward trend in US Treasuries. Investors are keeping a close eye on the forthcoming weekly debt auction, pivotal for market movements. With retail inflation and fluctuating oil prices in play, the Reserve Bank of India may entertain further rate hikes. Although benchmark Brent crude holds steady, it remains vulnerable to geopolitical shifts, prompting caution among traders as they await auction results.
At the interbank foreign exchange market, the rupee opened at 93.25 and gained further to trade at 93.15 against the greenback, up 17 paise from its previous close
The Indian rupee has shown remarkable strength, breaking the 93 per dollar barrier for the first time since April. This positive shift was fueled by impressive foreign portfolio investments, exceeding $12 billion in November alone. Consequently, the rupee has left its Asian peers behind as it thrives against a strong dollar, all while navigating the Federal Reserve's anticipated hawkish stance, showcasing an encouraging signal for the Indian market.
January Brent oil futures were at $92.44, up by 0.50%, and January crude oil futures on WTI (West Texas Intermediate) were at $82.90, up by 0.56%
JD Vance defended President Donald Trump's diplomatic engagement with Russian President Vladimir Putin regarding American interests. The discussion included the potential for reforming the United Nations during a trilateral meeting with Chinese President Xi Jinping. Their gathering focused on significant global challenges such as security and energy cooperation. Following these discussions, a joint declaration was adopted to enhance the UN's effectiveness in maintaining peace.
Max Healthcare surged nearly 5% in early trade to ₹1,090 on the NSE, leading the Nifty 50 gainers, while Apollo Hospitals gained 4% to hit a fresh 52-week high of ₹9,097
Rupee gained 17 paise to trade at 93.15 against the US dollar in early trade on Friday. The appreciation was supported by strong foreign fund inflows into the domestic equity markets. Despite higher crude prices and negative stock market sentiment, the currency showed resilience. Analysts expect slight positive bias in rupee trading due to declining crude and gold prices.
SELLAS Life Sciences shares plunged nearly 20% after the biotechnology company priced a $150 million public offering at $13 per share, a discount of around 28% to its previous close. The sell-off followed a sharp rally triggered by positive Phase 3 REGAL trial results for its experimental leukemia vaccine.